Have had a chance to cover more than 3 miilion shares short, 20% float, several times. Too greedy IMO and now we are just at the corner of good news hanging over for next weeks. Partnership in China and other European countries will sky jump PPS 15-20% over and over until the price is at the right range between 6 and 8 bucks before year end, considering the company is not taken over by another pharma. Even with a possible general markets melt-down some will be surprised of what an oversold stock can give after being frozen for so long on no apparent reason and an FDA approved-TEVA partenered product. Enjoy the juice shorts, it´s about time.
Nice post cancunfish. I think you are correct. ALXA quietly continues to knock out milestones. pipline development, FDA approval, sales, now reaching global sales, more pipeline develpment. for having such #$%$ executives we do seem to be moving in the right direction right CF? The correction will happen, its only a matter of time.
Company deserves more than a $75M market cap with or without any of the things you mentioned. The fact is that Adasuve is gaining traction and continues to move toward a global launch. Investing is based on current and future potential, and in the case of ALXA that significantly outweighs current valuation.